However, it has been reported that G6PC expression is upregulated in glioblastoma and ovarian cancer, and this upregulated G6PC expression promotes cell proliferation and an aggressive phenotype, indicating that G6PC may also play a role as an oncogene [9, 10]. Here, G6PC1 is linked to ovarian cancer.